Tandem Diabetes Care, Inc. (TNDM): Price and Financial Metrics

Tandem Diabetes Care, Inc. (TNDM): $39.52

3.32 (-7.75%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

TNDM Price/Volume Stats

Current price $39.52 52-week high $53.69
Prev. close $42.84 52-week low $13.82
Day low $39.04 Volume 2,052,070
Day high $43.46 Avg. volume 1,675,695
50-day MA $43.22 Dividend yield N/A
200-day MA $28.92 Market Cap 2.55B

TNDM Stock Price Chart Interactive Chart >


Tandem Diabetes Care, Inc. (TNDM) Company Bio


Tandem Diabetes Care, Inc. focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. The company was founded in 2006 and is based in San Diego, California.


TNDM Latest News Stream


Event/Time News Detail
Loading, please wait...

TNDM Latest Social Stream


Loading social stream, please wait...

View Full TNDM Social Stream

Latest TNDM News From Around the Web

Below are the latest news stories about TANDEM DIABETES CARE INC that investors may wish to consider to help them evaluate TNDM as an investment opportunity.

DexCom's (DXCM) G7 CGM Connects With Tandem's Insulin Pump

Dexcom's (DXCM) G7 integrates with Tandem's t:slim X2, revolutionizing diabetes care. A perfect combination of accuracy and innovation, this synergy sets a new standard in continuous glucose monitoring.

Yahoo | December 19, 2023

Here's Why You Should Retain Tandem Diabetes (TNDM) Now

Investors remain optimistic about Tandem Diabetes (TNDM), backed by the impressive spree of product introductions.

Yahoo | December 19, 2023

Tandem Diabetes (TNDM) Avails Tandem Source in the United States

Tandem Diabetes (TNDM) announces the full U.S. launch of Tandem Source, a new diabetes management platform for customers and healthcare providers.

Yahoo | December 14, 2023

Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers

SAN DIEGO, December 12, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of Tandem Source, a diabetes management platform for insulin pump users and healthcare providers (HCPs). Tandem Source is designed to bring together the features of Tandem’s legacy t:connect, t:connect HCP, and t:connect Portal offerings with new comprehensive data reporting in one central, scalable platform. Tandem Source is now availabl

Yahoo | December 12, 2023

Tandem Diabetes (TNDM) Launches Dexcom G7 Integrated t:slim X2

Tandem Diabetes' (TNDM) t:slim X2 is the first AID system in the world to feature Dexcom's most advanced CGM technology.

Yahoo | December 7, 2023

Read More 'TNDM' Stories Here

TNDM Price Returns

1-mo -23.60%
3-mo 17.30%
6-mo 27.81%
1-year 58.02%
3-year -60.23%
5-year -34.68%
YTD 33.60%
2023 -34.19%
2022 -70.14%
2021 57.32%
2020 60.51%
2019 56.99%

Continue Researching TNDM

Here are a few links from around the web to help you further your research on Tandem Diabetes Care Inc's stock as an investment opportunity:

Tandem Diabetes Care Inc (TNDM) Stock Price | Nasdaq
Tandem Diabetes Care Inc (TNDM) Stock Quote, History and News - Yahoo Finance
Tandem Diabetes Care Inc (TNDM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!